Kevin Bitterman - Profile and Investment Details

Investor Profile

Kevin Bitterman is a Venture Capital, Private Equity Firm, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Neuronetics, Inc., Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine, Gemini Therapeutics, Bicycle TherapeuticsHarbour Biomed, Aerovate Therapeutics, Generation Bio, Padlock Therapeutics, Lysosomal Therapeutics, UNUM Therapeutics, Scorpion Therapeutics, Pulmatrix, Morphic Therapeutic, Disarm Therapeutics, Kymera Therapeutics, Avrobio, Veracode, Bridj, Cogent Biosciences, Ikena Oncology, Visterra Inc., Wedding Spot, Surface Oncology, Delinia, Quench Bio, Plastiq, Translate Bio, Akero Therapeutics, Skillz, Vedere Bio, PillPack, Visterra, Nimbus Therapeutics, Kinaset Therapeutics, HotSpot Therapeutics, ZappRx, Indalo Therapeutics, Appcues, Rodin Therapeutics, Intellia Therapeutics, Secret Escapes, Replimune Group, TARIS Biomedical, Synlogic, InsightSquared, Dyne Therapeutics, Judo Bio, SimpleReach, Follica, Obsidian Therapeutics, Paracosm, Xilio Therapeutics, Accent Therapeutics, Neuronetics, Vets First Choice, Disc Medicine, Navitor Pharmaceuticals, Raze Therapeutics, Be Biopharma, Spero Therapeutics, Korro Bio, Arkuda Therapeutics, Cadent Therapeutics, JenaValve Technology, nChroma Bio, Appcito, Kala Pharmaceuticals, Genocea Biosciences, Viridian Therapeutics, Day One Biopharmaceuticals, Q32 Bio, Kinvey, Triplet Therapeutics, Affinia Therapeutics, IFM Therapeutics, Biolex Therapeutics, CardFlight, . Over time, Kevin Bitterman has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kevin Bitterman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Immunotherapy, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Startups, Finance, Bioinformatics, Biotechnology, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Precision Medicine, Clinical Trials, Gene Therapy, Technology Transfer, Health Diagnostics, Digital Health, Medical, Information Technology, B2B, Therapeutics, Cellular Therapy, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Kevin Bitterman, as their portfolio suggests a familiarity and interest in this area.

Understanding Kevin Bitterman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.